Juergen Willmann - Publications

Affiliations: 
2006-2008 Radiology Stanford University, Palo Alto, CA 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bose RJ, Kumar SU, Zeng Y, Afjei R, Robinson E, Lau K, Bermudez A, Habte F, Pitteri SJ, Sinclair R, Willmann JK, Massoud TF, Gambhir SS, Paulmurugan R. Correction to "Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents". Acs Nano. PMID 37721437 DOI: 10.1021/acsnano.3c08363  0.681
2019 Kimura RH, Wang L, Shen B, Huo L, Tummers W, Filipp FV, Guo HH, Haywood T, Abou-Elkacem L, Baratto L, Habte F, Devulapally R, Witney TH, Cheng Y, Tikole S, ... ... Willmann J, et al. Evaluation of integrin αvβ cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nature Communications. 10: 4673. PMID 31611594 DOI: 10.1038/S41467-019-11863-W  0.69
2019 Stern LA, Lown P, Kobe AC, Abou-Elkacem L, Willmann JK, Hackel BJ. Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276. Acs Combinatorial Science. PMID 30620189 DOI: 10.1021/acscombsci.8b00156  0.565
2018 Jc Bose R, Uday Kumar S, Zeng Y, Afjei R, Robinson E, Lau K, Bermudez A, Habte F, Pitteri SJ, Sinclair R, Willmann JK, Massoud TF, Gambhir SS, Paulmurugan R. Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents. Acs Nano. PMID 30346694 DOI: 10.1021/Acsnano.8B02587  0.689
2018 Tummers WS, Willmann JK, Bonsing BA, Vahrmeijer AL, Gambhir SS, Swijnenburg RJ. Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer. Pancreas. 47: 675-689. PMID 29894417 DOI: 10.1097/Mpa.0000000000001075  0.434
2018 Chowdhury SM, Lee T, Bachawal SV, Devulapally R, Abou-Elkacem L, Yeung TA, Wischhusen J, Tian L, Dahl J, Paulmurugan R, Willmann JK. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29758233 DOI: 10.1016/J.Jconrel.2018.05.009  0.471
2018 Poullos PD, Tseng JJ, Melcher ML, Concepcion W, Loening AM, Rosenberg J, Willmann JK. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant. Ajr. American Journal of Roentgenology. 1-9. PMID 29470153 DOI: 10.2214/Ajr.17.18725  0.608
2018 Tummers WS, Kimura RH, Abou-Elkacem L, Vahrmeijer AL, Swijnenburg RJ, Willmann JK, Gambhir SS. Development and preclinical validation of a cysteine knottin peptide targeting Integrin αvβ6 for near-infrared fluorescent-guided surgery in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29298796 DOI: 10.1158/1078-0432.Ccr-17-2491  0.424
2016 Devulapally R, Foygel K, Sekar TV, Willmann JK, Paulmurugan R. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. Acs Applied Materials & Interfaces. 8: 33412-33422. PMID 27960411 DOI: 10.1021/Acsami.6B08153  0.458
2015 Hwang GL, van den Bosch MA, Kim YI, Katzenberg R, Willmann JK, Paulmurugan R, Gambhir SS, Hofmann L. Development of a High-Throughput Molecular Imaging-Based Orthotopic Hepatocellular Carcinoma Model. CurēUs. 7: e281. PMID 26180705 DOI: 10.7759/Cureus.281  0.614
2015 Sampath SC, Sampath SC, Mosci C, Lutz AM, Willmann JK, Mittra ES, Gambhir SS, Iagaru A. Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone. Clinical Nuclear Medicine. 40: e173-7. PMID 25140557 DOI: 10.1097/Rlu.0000000000000560  0.627
2013 Chen IY, Gheysens O, Li Z, Rasooly JA, Wang Q, Paulmurugan R, Rosenberg J, Rodriguez-Porcel M, Willmann JK, Wang DS, Contag CH, Robbins RC, Wu JC, Gambhir SS. Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemia. Human Gene Therapy Methods. 24: 279-88. PMID 23937265 DOI: 10.1089/Hgtb.2013.028  0.724
2011 Gheysens O, Chen IY, Rodriguez-Porcel M, Chan C, Rasooly J, Vaerenberg C, Paulmurugan R, Willmann JK, Deroose C, Wu J, Gambhir SS. Non-invasive bioluminescence imaging of myoblast-mediated hypoxia-inducible factor-1 alpha gene transfer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 1124-32. PMID 21267661 DOI: 10.1007/S11307-011-0471-9  0.669
2010 Nielsen CH, Kimura RH, Withofs N, Tran PT, Miao Z, Cochran JR, Cheng Z, Felsher D, Kjær A, Willmann JK, Gambhir SS. PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide. Cancer Research. 70: 9022-30. PMID 21062977 DOI: 10.1158/0008-5472.Can-10-1338  0.736
2009 Paulmurugan R, Padmanabhan P, Ahn BC, Ray S, Willmann JK, Massoud TF, Biswal S, Gambhir SS. A novel estrogen receptor intramolecular folding-based titratable transgene expression system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1703-11. PMID 19654568 DOI: 10.1038/Mt.2009.171  0.711
2008 Lutz AM, Willmann JK, Cochran FV, Ray P, Gambhir SS. Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes. Plos Medicine. 5: e170. PMID 18715113 DOI: 10.1371/Journal.Pmed.0050170  0.678
2004 Weishaupt D, Willmann JK, Lutz AM, Marincek B. Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver. European Radiology. 14: C5-6. PMID 15113059  0.575
2004 Lutz A, Willmann J, Goepfert K, Marincek B, Weishaupt D. Kontrastmittelanreicherungsverhalten hepatozellulärer Karzinome in der dynamischen Gadolinium- und Eisenoxid-verstärkten T1-gewichteten MRT RöFo - Fortschritte Auf Dem Gebiet Der RöNtgenstrahlen Und Der Bildgebenden Verfahren. 176. DOI: 10.1055/S-2004-827565  0.564
Show low-probability matches.